Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 38.81 USD 2.51% Market Closed
Market Cap: 3.2B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Relative Value

The Relative Value of one VRNA stock under the Base Case scenario is 15.98 USD. Compared to the current market price of 38.81 USD, Verona Pharma PLC is Overvalued by 59%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VRNA Relative Value
Base Case
15.98 USD
Overvaluation 59%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
0
Median 3Y
11.3
Median 5Y
0
Industry
2.5
Forward
147.7
vs History
vs Industry
Median 3Y
-17.8
Median 5Y
-11
Industry
21.9
Forward
-22.5
vs History
vs Industry
Median 3Y
-23.4
Median 5Y
-23.4
Industry
16.5
vs History
vs Industry
Median 3Y
-30.6
Median 5Y
-30.6
Industry
23.6
vs History
1
vs Industry
9
Median 3Y
5.8
Median 5Y
5.8
Industry
2.1
vs History
19
vs Industry
0
Median 3Y
7.7
Median 5Y
0
Industry
2.6
Forward
137.6
vs History
4
vs Industry
0
Median 3Y
0
Median 5Y
0
Industry
5.2
vs History
vs Industry
Median 3Y
-13.9
Median 5Y
-7.8
Industry
13.3
Forward
-37.2
vs History
vs Industry
Median 3Y
-13.8
Median 5Y
-7.7
Industry
16.6
Forward
-14.9
vs History
vs Industry
Median 3Y
-19.4
Median 5Y
-19.4
Industry
15.6
vs History
vs Industry
Median 3Y
-19.4
Median 5Y
-19.4
Industry
19.1
vs History
6
vs Industry
2
Median 3Y
33.9
Median 5Y
27.4
Industry
1.9

Multiples Across Competitors

VRNA Competitors Multiples
Verona Pharma PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Verona Pharma PLC
NASDAQ:VRNA
3.2B USD 560.6 -20.5 -19 -18.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
UK
Verona Pharma PLC
NASDAQ:VRNA
Average P/E: 32.4
Negative Multiple: -20.5
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top